Condition
Statins
Total Trials
7
Recruiting
0
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
14.3%
1 terminated out of 7 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Unknown3
Completed2
Terminated1
Active Not Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06635252Completed
Statins, Cholesterol and Cognitive Decline in Alzheimer's
NCT05537948Phase 4Active Not Recruiting
Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients
NCT04857632Phase 2Unknown
Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage
NCT04477590Not ApplicableUnknown
Interactions of Medicine and Exercise With Meal Timing
NCT05347823Unknown
Study of Adherence to Antihypertensive Drugs and Statins by Hair Analysis
NCT03485742TerminatedPrimary
Statin Eligibility Prior to Myocardial InfarCtion
NCT01200836Completed
Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol
Showing all 7 trials